•  
  •  
  •  
  •  

2025-10-02 01:03:36

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  DIAMINESandCHEMICALS

Stock Report

  • Diamines and Chemicals Ltd Q2 FY2025 consolidated PAT at Rs. 2.46 crore
  • Diamines and Chemicals Limited receives ISO certificate
  • Diamines and Chemicals Ltd reports Rs. 2.80 crore consolidated PAT in Q3 FY24
  • DACL Fine Chem Ltd receives CTE from GPCB for proposed new plant
  • Diamines and Chemicals Ltd receives GPCB approval for expansion at its Vadodara unit
  • Diamines and Chemicals Limited gets listing approval from NSE
  • Diamines and Chemicals Ltd Q1 FY2024 consolidated PAT drops to Rs. 7 crore
  • Diamines and Chemicals Limited recommends final dividend of Rs. 3
  • Diamines and Chemicals Ltd consolidated Q4FY23 PAT increases to Rs. 9.57 crores
  • Diamines and Chemicals Ltd Q3 FY2023 consolidated profit slips QoQ to Rs. 8.93 crores
  • Diamines and Chemicals Ltd consolidated Q1 FY2022-23 net profit rises to Rs. 11.02 crores
  • Diamines & Chemicals Ltd Board recommends Final Dividend of Rs. 3
  • Diamines and Chemicals Ltd Q4 FY2022 consolidated PAT climbs to Rs. 7.16 crores
  • Diamines and Chemicals Q3FY22 consolidated PAT declines to Rs. 2.47 crores
  • Diamines and Chemicals receives Environment Clearance for expansion
  • Diamines and Chemicals Ltd to sell wind power projects
  • Diamines and Chemicals Ltd board approves capex of Rs. 14.50 crore
  • Diamines and Chemicals Ltd posts consolidated net profit of Rs. 3.35 crore in Q2

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024